My portfolio has gotten very overweighted in recent months in biotech as I have added to existing holdings and added new ones on the selloff in the sector that brought the SPDR Biotech ETF (XBI) down nearly 30% from its February highs before some slight improvement over the past weekThis means I need to find some new names out of biotech to execut...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.